Myocardial infarction, with ST-elevation

I9_STEMI

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I21.1, I21.2, I21.3 Cause of death: ICD-10 — I21.1, I21.2, I21.3 2 out of 7 registries used, show all original rules.	7656
4. Check minimum number of events None	7656
5. Include endpoints None	7656
6. Filter based on genotype QC (FinnGen only)	7656

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	I9_STEMI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I21[1-3]
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I21[1-3]
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Myocardial infarction, with ST-elevation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7656	1862	5794
Unadjusted period prevalence (%)	2.09	0.63	2.55
Median age at first event (years)	66.93	69.94	65.97

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6962: Matched controls
69611

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

1244.4

323.0

572

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

9.9

323.0

1761

2302

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

16384.0

323.0

2075

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

3.4

323.0

3295

14707

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

13.2

323.0

5209

12819

ZXD05

NOMESCO Finland

Urgent procedure

2.8

323.0

3017

14738

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

14718.9

323.0

1228

AN1

Coronary angiography

5.8

323.0

2619

6504

I21.1

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

1945.6

323.0

516

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

9.1

323.0

1596

2200

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

7.6

323.0

1055

1594

C09AA05

ATC

ramipril; oral

3.4

323.0

3308

14496

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

9.4

323.0

727

853

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

8.1

323.0

4432

12330

I25.2

ICD-10 Finland

Old myocardial infarction

12.3

323.0

2926

3861

B01AC04

ATC

clopidogrel; oral

6.2

323.0

3297

8845

B01AC24

ATC

ticagrelor; oral

17.6

323.0

1395

978

C07AB07

ATC

bisoprolol; oral

3.2

323.0

4829

28812

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

4.7

323.0

1722

4542

AN3

Balloon angioplasty and metallic stent

10.4

323.0

1065

1192

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

14525.1

323.0

2080

C01DA14

ATC

isosorbide mononitrate; oral

3.5

323.0

2797

11094

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

5.1

323.0

4046

14867

C10AA05

ATC

atorvastatin; oral

2.9

323.0

3927

21531

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

2253.1

323.0

648

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

9.9

323.0

1950

2642

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

+∞

323.0

539

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.6

323.0

2168

7773

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

5724.8

323.0

540

I25.1

ICD-10 Finland

Atherosclerotic heart disease

8.3

323.0

4891

15421

AN4

Balloon angioplasty and drug eluding stent

7.9

323.0

951

1374

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.8

323.0

2039

6817

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.1

311.2

2207

9114

I21.20

ICD-10 Finland

Acute transmural myocardial infarction with other localization no detected stenosis of coronary artery

+∞

293.8

280

ZXD00

NOMESCO Finland

Emergency procedure

8.1

285.2

680

915

I25

ICD-10 Finland

Chronic ischaemic heart disease

5.0

277.3

985

2228

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

3.6

276.3

1485

4932

Angiography of the heart and coronary arteries

3.9

273.5

1291

3845

AN2

Balloon angioplasty, including several vessels

6.8

258.1

693

1107

C10AX09

ATC

ezetimibe; oral

3.6

256.4

1362

4453

C10AA01

ATC

simvastatin; oral

2.4

254.5

4257

27712

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

231.1

1929

8543

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.7

225.3

1110

3381

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.3

224.1

916

2360

I20.09

ICD-10 Finland

Unstable angina

3.9

220.7

1003

2847

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.8

213.5

1028

3062

I21.30

ICD-10 Finland

Acute transmural myocardial infarction with unspecified location no detected stenosis of coronary artery

+∞

211.5

202

Single vessel balloon catheter extension

6.1

209.3

611

1082

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

5.2

200.2

667

1382

I21.3

ICD-10 Finland

Acute transmural myocardial infarction of unspecified site

1839.6

195.6

189

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

4.2

191.9

808

2125

I21.12

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

1787.2

190.3

184

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

8.1

183.1

434

569

C07AB02

ATC

metoprolol; systemic

2.3

179.1

2302

12497

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.8

172.4

812

2348

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

6.1

169.0

492

862

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.3

168.4

2018

10532

280

Kela drug reimbursment

Clopidogrel

7.1

162.0

419

625

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

3.5

161.2

843

2647

C03CA01

ATC

furosemide; systemic

1.9

141.5

3086

20307

I20.01

ICD-10 Finland

Unstable angina

4.3

139.5

553

1358

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

137.0

2183

12680

I20.00

ICD-10 Finland

Unstable angina

4.1

136.7

579

1512

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.8

130.4

944

3683

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

6.3

129.5

363

602

FNG10

NOMESCO Finland

Embolectomy of coronary artery

49.8

128.3

156

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.5

117.1

1036

4524

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

5.3

107.6

349

691

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

106.5

1670

9459

K76

ICPC

Ischaemic heart dis without angina

4.5

105.6

402

943

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.3

104.7

1176

5765

ANB

Coronary thrombectomy

30.6

104.5

141

FN2EC

NOMESCO Finland

Transcatheter coronary thrombectomy

50.4

102.3

124

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

3.7

95.6

451

1284

I50.1

ICD-10 Finland

Left ventricular failure

2.8

94.9

692

2685

C10AA07

ATC

rosuvastatin; oral

1.9

92.6

1789

10852

B01AC22

ATC

prasugrel; oral

20.5

91.9

139

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

4.6

91.2

333

748

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

6.3

88.6

247

406

XF402

NOMESCO Finland

ECG with work load test

2.2

88.3

1003

4907

Coronary artery bypass surgery

3.5

86.4

431

1282

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

2.8

84.7

595

2249

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

5.1

81.7

271

549

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

81.4

2281

15449

WX872

NOMESCO Finland

Intensive care

2.9

80.2

540

1986

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.5

79.0

393

1165

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

76.0

1572

9651

I50.0

ICD-10 Finland

Congestive heart failure

2.1

75.3

925

4660

I21.31

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization stenosed coronary artery

+∞

75.1

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

74.7

2027

13526

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

8.7

71.7

159

186

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.8

68.9

491

1865

A10BA02

ATC

metformin; oral

1.6

68.2

2236

15638

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.2

67.9

730

3453

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

3.5

67.1

331

973

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

66.6

609

2658

I21.18

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

64.7

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

5.6

62.7

191

351

Catheterization and pressure measurement of the left side of the heart

3.7

61.2

284

794

A02BC02

ATC

pantoprazole; systemic

1.5

59.9

4113

33945

Z2221

NOMESCO Finland

Medical doctor

1.6

59.6

1736

11668

R4110

NOMESCO Finland

Physiotherapy

1.6

58.8

1713

11508

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.7

57.2

429

1677

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

55.8

3031

23600

C03DA01

ATC

spironolactone; oral

1.9

54.9

953

5443

Z3231

NOMESCO Finland

Registered nurse

1.6

54.2

1859

12977

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.4

53.6

490

2132

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

53.1

854

4742

A10AE04

ATC

insulin glargine; parenteral

2.0

52.2

758

4048

Z3226

NOMESCO Finland

Physiotherapist

1.7

51.2

1208

7600

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

3.2

50.1

273

866

WX892

NOMESCO Finland

Monitored bed care

2.1

50.1

627

3153

I21

ICD-10 Finland

Acute myocardial infarction

13.6

49.1

C10AA03

ATC

pravastatin; oral

2.0

48.0

629

3219

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

46.8

4269

36376

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

46.7

1417

9528

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.6

46.7

360

1426

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

46.4

1134

7186

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.3

45.9

176

416

AA1

Conventional CABG

3.0

45.8

275

933

ZXE00

NOMESCO Finland

One hour or less

1.5

45.7

2390

18210

C10AA04

ATC

fluvastatin; oral

1.9

45.6

778

4395

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.1

45.4

576

2910

K84

ICPC

Heart disease other

3.0

44.9

272

930

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.4

43.9

396

1708

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

43.6

793

4577

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

3.5

43.5

212

618

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

6.3

43.1

117

187

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

4.2

42.6

168

408

Multi-vessel balloon catheter extension

5.7

41.8

124

222

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.0

41.8

594

3136

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

41.5

1661

11893

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

3.8

40.8

180

484

A10AA02

ATC

2.6

40.2

308

1217

WX890

NOMESCO Finland

Intesive care monitoring

5.1

39.3

127

252

FL1AC

NOMESCO Finland

Left cardioangiography

3.4

38.9

198

598

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

6.6

38.6

101

154

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.2

37.2

202

640

I47.2

ICD-10 Finland

Ventricular tachycardia

3.0

37.0

228

789

I21.22

ICD-10 Finland

Acute transmural myocardial infarction with other coronary artery localization

+∞

36.5

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

3.4

35.7

177

524

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

3.1

35.6

205

678

I23.0

ICD-10 Finland

Haemopericardium as current complication following acute myocardial infarction

14.9

35.2

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

35.1

1285

8963

K75

ICPC

Acute myocardial infarction

10.5

34.7

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.4

34.7

175

526

I20.91

ICD-10 Finland

Angina pectoris, unspecified

3.3

34.3

183

573

I22.8

ICD-10 Finland

Subsequent myocardial infarction of other sites

13.5

33.9

I22.19

ICD-10 Finland

recurrent infarction in diaphragmatic wall unspecified coronary artery status

15.9

31.9

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

7.5

31.9

102

T90

ICPC

Diabetes non-insulin dependent

1.4

30.8

1569

11692

R07.3

ICD-10 Finland

Other chest pain

1.8

30.5

590

3457

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

30.3

479

2620

AP1

Catheterization of the left side of the heart

2.9

30.1

191

674

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.5

29.6

244

1003

A10BB12

ATC

glimepiride; oral

1.7

29.4

670

4122

ZX120

NOMESCO Finland

Intravenous

1.7

28.4

599

3602

111

Conventional CABG

3.8

28.4

124

333

K74

ICPC

Ischaemic heart dis with angina

3.3

27.8

143

438

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

27.1

654

4087

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

26.6

539

3199

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

5.0

26.4

170

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

4.0

26.2

107

271

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

4.1

26.2

105

262

A10AA01

ATC

2.8

26.1

169

606

A10BK03

ATC

empagliflozin; oral

1.8

25.8

428

2380

H3603, E103

ICD-10 Finland

5.4

25.5

143

FXG00

NOMESCO Finland

Insertion and use of IABP

7.8

25.1

I20.0

ICD-10 Finland

Unstable angina

3.8

25.1

109

292

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

24.9

910

6297

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

24.8

628

3970

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.4

24.7

222

957

C08CA01

ATC

amlodipine; oral

1.3

24.6

2497

20717

A10AE05

ATC

insulin detemir; parenteral

1.9

24.2

367

1977

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.4

24.0

212

906

I21.28

ICD-10 Finland

Acute transmural myocardial infarction with different localization different occlusion in coronary artery

+∞

24.0

B01AC07

ATC

dipyridamole; systemic

1.7

23.9

528

3214

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

23.7

2262

18566

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

12.0

23.7

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.8

23.4

156

570

B01AA03

ATC

warfarin; systemic

1.3

23.3

1805

14349

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

23.2

532

3269

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

12.5

23.0

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.5

23.0

188

774

1CX08

NOMESCO Finland

5.8

22.8

113

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

22.8

1019

7344

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

22.7

572

3610

C01BD01

ATC

amiodarone; systemic

2.1

22.6

262

1271

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.3

22.3

210

929

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

3.4

22.0

110

331

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

3.3

22.0

112

342

XF404

NOMESCO Finland

Ambulatory ECG

1.6

22.0

626

4080

205

Kela drug reimbursment

Chronic hypertension

1.3

21.8

2278

18887

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.3

21.8

209

933

J01FF01

ATC

clindamycin; systemic

1.4

21.4

1489

11606

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

4.1

21.2

209

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

2.6

21.0

157

613

A98

ICPC

Health maint/preventive medicine

0.8

20.9

4780

51529

ANE

Coronary internal ultrasound (IVUS)

6.4

20.9

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

4.9

20.6

137

M01AH05

ATC

etoricoxib; oral

0.8

20.5

2085

24746

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.9

20.5

307

1649

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

20.1

1979

16229

R2110

NOMESCO Finland

Giving the first information

1.9

20.0

295

1574

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.1

20.0

110

357

C09AA04

ATC

perindopril; oral

1.7

19.7

396

2341

A10BB01

ATC

glibenclamide; oral

1.7

19.5

458

2832

C08CA07

ATC

nisoldipine; oral

2.6

19.5

148

585

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

19.5

387

2279

I20.9

ICD-10 Finland

Angina pectoris, unspecified

2.8

19.2

128

470

WX722

NOMESCO Finland

PEEP

1.8

19.0

324

1820

AA2

Off pump CABG sternotomy

4.2

18.7

170

R06.0

ICD-10 Finland

Dyspnoea

1.3

18.5

1493

11874

N07BA03

ATC

varenicline; oral

2.1

18.3

209

1010

I20.19

ICD-10 Finland

Angina angiospastic

4.9

18.3

120

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

18.3

401

2437

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

18.1

1770

14464

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.4

18.0

149

C10AX13

ATC

evolocumab; parenteral

12.4

17.6

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

17.6

184

856

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.9

17.3

103

354

TK800

NOMESCO Finland

Hemodialysis

2.3

17.3

159

698

TFN40

NOMESCO Finland

Catheterisation of heart with balloon widening of coronary vessels

4.9

17.3

115

I20

ICD-10 Finland

Angina pectoris

2.5

17.2

138

566

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.4

17.1

147

624

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

4.0

17.0

172

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

17.0

103

356

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.8

16.9

187

A02BC01

ATC

omeprazole; systemic

1.3

16.9

1687

13795

287

Kela drug reimbursment

Ticagrelor 60 mg

17.4

16.9

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.4

16.9

244

I20.10

ICD-10 Finland

Angina angiospastic

4.5

16.8

132

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

3.8

16.8

189

A11

ICPC

Chest pain NOS

1.6

16.6

425

2691

I20.8

ICD-10 Finland

Other forms of angina pectoris

3.1

16.6

307

WX900

NOMESCO Finland

Resuscitation

4.1

16.3

159

Z2446

NOMESCO Finland

Social worker

1.7

16.3

335

1996

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

16.2

858

6356

SPAT1262

SPAT

Handing over of treatment supplies

1.3

16.2

1149

8942

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

16.1

887

6623

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

3.2

15.8

257

I22.99

ICD-10 Finland

Recurrent infarction with unspecified location unspecified coronary artery status

5.5

15.8

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.0

15.7

160

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

15.7

2065

17454

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.2

15.7

154

698

I50

ICD-10 Finland

Heart failure

1.8

15.7

263

1470

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

15.6

270

1525

FN2CD

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of vein graft

8.1

15.5

FNA96

NOMESCO Finland

Other connection to coronary artery from internal mammary artery

4.8

15.3

104

5CM18

NOMESCO Finland

4.7

15.2

109

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

5.3

15.2

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

15.2

1831

15305

C08DB01

ATC

diltiazem; oral

1.6

15.2

456

3010

XPX08

NOMESCO Finland

Intraoperative flow measurement

2.8

15.1

333

315

Kela drug reimbursment

Clopidogrel

2.5

15.0

113

449

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

14.9

345

2127

TFN50

NOMESCO Finland

Catheterisation of heart with application of stent

6.2

14.8

I22.10

ICD-10 Finland

recurrent infarction in the diaphragmatic wall no detected stenosis of coronary artery

11.3

14.7

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.8

14.6

161

I21.13

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

14.6

R07.2

ICD-10 Finland

Precordial pain

2.3

14.6

130

565

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.3

14.4

215

NHQ40

NOMESCO Finland

Amputation of toe

2.2

14.4

149

691

A11CC03

ATC

alfacalcidol; systemic

2.1

14.2

161

780

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

14.1

747

5530

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.1

14.1

158

762

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

14.1

217

1183

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

14.0

1079

13382

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.6

13.9

392

2544

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.0

13.9

170

849

WX730

NOMESCO Finland

Conventional respirator

2.3

13.9

128

564

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.1

13.9

149

705

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

13.9

303

1837

WX930

NOMESCO Finland

Thepapeutic hypothermia

8.6

13.7

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

13.7

503

3471

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

13.6

312

1918

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

6.4

13.6

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.0

13.5

248

C09DX04

ATC

valsartan and sacubitril; oral

3.1

13.4

227

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

13.4

297

1811

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

1.8

13.4

236

1344

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.3

13.4

125

557

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

13.2

950

7386

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

5.0

13.1

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.5

13.0

104

427

M04AA01

ATC

allopurinol; systemic

1.3

13.0

1020

8033

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

13.0

4318

46270

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

12.9

614

4457

I22.11

ICD-10 Finland

recurrent infarction in the diaphragmatic wall stenosed coronary artery

22.5

12.9

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

3.4

12.8

186

I21.02

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

6.9

12.8

FNC50

NOMESCO Finland

Aorto-coronary venous bypass with five distal anastomoses

5.2

12.8

M10.9

ICD-10 Finland

Gout, unspecified

1.5

12.8

475

3286

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

2.3

12.7

122

547

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

12.7

280

1708

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

12.6

587

4244

A12BA01

ATC

potassium chloride; oral

1.5

12.6

391

2600

R03BB04

ATC

tiotropium bromide; inhalant

1.4

12.4

720

5410

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

12.4

427

5955

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.3

12.3

114

503

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.3

12.2

116

518

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

12.2

546

3918

SAA02

NOMESCO Finland

Basic examination of mouth

0.8

12.2

2189

24871

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.0

12.2

161

831

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.1

12.1

142

698

H3600, E103

ICD-10 Finland

3.6

12.0

144

T89

ICPC

Diabetes insulin dependent

1.9

11.9

163

855

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

1.9

11.8

168

889

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

11.8

242

1443

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

11.7

1636

13840

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

3.9

11.7

117

207

Kela drug reimbursment

Chronic arrhythmias

1.3

11.7

1070

8599

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.4

11.6

386

FN1ST

NOMESCO Finland

Endovascular thrombolytic therapy of coronary arteries

22.9

11.5

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

1.8

11.5

199

1129

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

2.4

11.5

390

AA1AD

NOMESCO Finland

CT of head and brain

1.2

11.5

1482

12417

R11

ICD-10 Finland

Nausea and vomiting

1.5

11.5

379

2556

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

10.0

11.5

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

11.4

311

2008

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

4.7

11.3

C08CA05

ATC

nifedipine; systemic

1.4

11.3

457

3220

ZXE90

NOMESCO Finland

More than 22 hours

2.8

11.3

263

FXZ00

NOMESCO Finland

Off-pump cardiac operation

2.9

11.0

232

N18.0

ICD-10 Finland

End-stage renal disease

2.3

11.0

410

C08CA02

ATC

felodipine; oral

1.4

10.9

669

5073

C07AG02

ATC

carvedilol; oral

1.5

10.8

409

2838

AS7

Arrhythmia pacemaker insertion VVI (R) S

4.7

10.8

C10AA02

ATC

lovastatin; oral

1.5

10.8

329

2180

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

2.0

10.8

126

622

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

10.7

776

6032

H3601, E103

ICD-10 Finland

3.6

10.7

132

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

3.6

10.7

127

M01AX05

ATC

glucosamine; oral

0.8

10.7

729

9209

PE1AT

NOMESCO Finland

Femoral artery PTA

2.2

10.7

101

455

S82

ICPC

Naevus/mole

0.7

10.7

257

3831

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.7

10.6

304

4381

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

10.6

1416

16597

A10BH01

ATC

sitagliptin; oral

1.4

10.6

576

4284

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

3.5

10.5

139

N02AX02

ATC

tramadol; systemic, rectal

1.2

10.5

2484

22090

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

0.6

10.5

184

2930

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

9.2

10.5

R55

ICD-10 Finland

Syncope and collapse

1.3

10.5

693

5317

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.7

10.4

230

1407

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.7

10.3

248

386

Kela drug reimbursment

Ticagrelor 60 mg

32.5

10.3

WX882

NOMESCO Finland

High dependency care

1.8

10.3

160

879

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

10.3

939

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

2.4

10.2

335

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

10.2

227

1390

I34.02

ICD-10 Finland

Mitralysis insufficiency caused by ischemia

6.6

10.2

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

10.2

236

1462

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

3.9

10.1

103

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.1

10.1

112

542

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.2

10.1

102

474

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1.6

10.1

229

1412

J01MA12

ATC

levofloxacin; systemic

1.3

10.0

1145

9450

TFN04

NOMESCO Finland

2.9

10.0

200

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

10.0

831

10253

H3601, E113

ICD-10 Finland

2.1

10.0

111

539

PEN23

NOMESCO Finland

Plastic repair of femoral artery

2.6

9.9

284

C07AA05

ATC

propranolol; systemic

0.7

9.9

432

5812

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

9.9

397

2793

G04BD12

ATC

mirabegron; oral

0.7

9.9

296

4234

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

1.7

9.9

210

1272

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

0.8

9.9

1038

12478

A10BH05

ATC

linagliptin; oral

1.5

9.8

318

2139

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.4

9.8

317

N40

ICD-10 Finland

Hyperplasia of prostate

0.8

9.8

1540

17791

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.7

9.7

198

1187

K01

ICPC

Heart pain

2.2

9.7

421

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

9.6

704

5482

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

9.5

1368

11571

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.8

9.4

148

816

H3603, E113

ICD-10 Finland

2.5

9.4

286

FN2DA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of stent thrombosis

17.5

9.4

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.5

9.4

356

2476

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.2

9.4

391

I20.88

ICD-10 Finland

Other angina pectoris other occlusion in coronary artery

3.3

9.4

137

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

9.3

619

7859

XF409

NOMESCO Finland

Other special ECG

3.0

9.3

165

I22.89

ICD-10 Finland

recurrent infarction with other location unspecified coronary artery status

10.6

9.3

Z72.0

ICD-10 Finland

Tobacco use

2.0

9.2

107

530

K92

ICPC

Atherosclerosis/periph vascular dis

2.1

9.1

436

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

1.8

9.1

164

946

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.8

9.0

765

9425

I42.8

ICD-10 Finland

Other cardiomyopathies

3.6

9.0

105

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.9

8.9

180

I44.2

ICD-10 Finland

Atrioventricular block, complete

1.6

8.9

197

1209

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

8.9

218

1374

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.6

8.8

224

1422

C01BC04

ATC

flecainide; systemic

0.5

8.8

1326

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.8

8.8

I95.9

ICD-10 Finland

Hypotension, unspecified

2.0

8.7

104

521

R57.0

ICD-10 Finland

Cardiogenic shock

7.2

8.7

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.6

8.7

238

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.8

8.7

1628

18563

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

2.6

8.7

232

C09AA02

ATC

enalapril; systemic

1.2

8.7

1390

11880

I51.4

ICD-10 Finland

Myocarditis, unspecified

4.1

8.6

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.0

8.6

105

530

A12AA04

ATC

calcium carbonate; oral

2.0

8.6

107

544

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

2.6

8.6

227

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

8.5

975

8037

FN2EA

NOMESCO Finland

Coronary rotablation

3.7

8.5

CKC12

NOMESCO Finland

Photocoagulation of retina

1.6

8.5

199

1240

A10BK01

ATC

dapagliflozin; oral

1.6

8.5

215

1366

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

2.6

8.4

223

I20.08

ICD-10 Finland

Unstable angina

4.1

8.4

R1420

NOMESCO Finland

Assessment of rehabilitation needs and/or compilation of rehabilitation plan

7.3

8.4

A10AE06

ATC

insulin degludec; parenteral

1.9

8.4

122

655

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.5

8.4

256

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

2.7

8.4

201

H04AA01

ATC

glucagon; nasal, parenteral

2.3

8.3

326

I21.23

ICD-10 Finland

Acute transmural myocardial infarction with other localization embolus in coronary artery

+∞

8.3

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.3

8.3

338

H36.01

ICD-10 Finland

Diabetic maculopathy

2.3

8.3

327

L82

ICD-10 Finland

Seborrhoeic keratosis

0.8

8.3

460

5980

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

0.9

8.3

1960

21943

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.2

8.3

361

PHD99

NOMESCO Finland

Resection of other vein

0.6

8.2

1640

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.4

8.0

269

C09AA01

ATC

captopril; oral

1.7

8.0

161

963

Z01.2

ICD-10 Finland

Dental examination

0.8

8.0

1219

14162

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

7.9

679

5401

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.0

7.9

100

514

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.7

7.9

146

851

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

7.9

223

1460

L04AA06

ATC

mycophenolic acid; systemic

2.1

7.8

371

D01BA02

ATC

terbinafine; oral; topical

0.8

7.8

982

11624

J81

ICD-10 Finland

Pulmonary oedema

2.6

7.8

216

I21.48

ICD-10 Finland

Acute subendocardial infarction other occlusion in coronary artery

5.4

7.8

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.2

7.8

331

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.8

7.8

657

8110

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

8.4

7.8

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.5

7.8

246

1649

H02AB06

ATC

prednisolone; systemic

1.2

7.8

2590

23533

FNE01

NOMESCO Finland

Coronary bypass using free arterial graft of internal mammary artery, one graft

6.9

7.7

SPAT1097

SPAT

Recording of ECG

1.3

7.7

826

6758

D19

ICPC

Teeth/gum symptom/complaint

0.8

7.7

645

7960

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.7

7.6

164

999

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

0.7

7.6

352

4695

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

3.7

7.6

C07AB08

ATC

celiprolol; oral

1.6

7.6

193

1229

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.5

7.5

213

1393

M86.6

ICD-10 Finland

Other chronic osteomyelitis

3.3

7.5

106

ZPB22

NOMESCO Finland

Autograft of vein

2.7

7.5

178

PJA12

NOMESCO Finland

Sentinel node biopsy

0.6

7.4

1453

C10AB02

ATC

bezafibrate; oral

1.9

7.4

100

528

B04AC04

ATC

2.3

7.4

278

C09CA03

ATC

valsartan; oral

1.3

7.4

489

3755

XKD00

NOMESCO Finland

Uroflowmetry

0.8

7.4

948

11201

R04.0

ICD-10 Finland

Epistaxis

1.3

7.3

454

3450

XFL00

NOMESCO Finland

Cineangiography of left atrium and vetricle

3.9

7.3

I21.38

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization other occlusion in coronary artery

+∞

7.3

I21.32

ICD-10 Finland

Acute transmural myocardial infarction with unspecified coronary artery location

+∞

7.3

H3600, E113

ICD-10 Finland

2.0

7.3

468

PD5AD

NOMESCO Finland

CT of aorta

1.9

7.2

512

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

2.8

7.2

160

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

5.8

7.2

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.4

7.2

295

2087

XF640

NOMESCO Finland

1.6

7.2

181

1152

L57.0

ICD-10 Finland

Actinic keratosis

0.7

7.2

376

4927

E87.5

ICD-10 Finland

Hyperkalaemia

1.8

7.2

114

637

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.5

7.1

249

1709

C09CA01

ATC

losartan; oral

1.2

7.1

1358

11772

N19

ICD-10 Finland

Unspecified kidney failure

1.5

7.1

234

1585

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

0.3

7.1

470

SDA01

NOMESCO Finland

Simple parodonthologic therapy

0.8

7.1

623

7654

N083, E102

ICD-10 Finland

6.5

7.1

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

1.9

7.1

485

C03AA03

ATC

hydrochlorothiazide; oral

1.3

7.1

588

4658

I22.81

ICD-10 Finland

recurrent infarction with another location stenosed coronary artery

12.0

7.1

CKC15

NOMESCO Finland

Panretinal photocoagulation

2.4

7.1

242

B01AC05

ATC

ticlopidine; oral

5.3

7.1

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

10.0

7.0

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

1.7

7.0

138

824

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

7.0

201

1323

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

2.8

6.9

146

PEC23

NOMESCO Finland

Suture of common femoral artery

3.2

6.9

102

C02DE04

ATC

1.5

6.9

227

1539

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

6.9

838

6948

ZXC96

NOMESCO Finland

Robot assisted procedure

0.5

6.9

918

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.4

6.9

284

2015

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

0.8

6.9

636

7769

FM3CN

NOMESCO Finland

Heart perfusion isotope imaging both at rest and with exercise

4.0

6.9

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

6.8

226

1532

OAA67

SPAT

0.5

6.8

1025

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.5

6.8

205

1362

I22.90

ICD-10 Finland

recurrent infarction with unspecified location no detected stenosis of coronary artery

4.8

6.8

FNE96

NOMESCO Finland

Coronary bypass using other free arterial graft

4.3

6.8

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.8

6.8

506

6341

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.5

6.8

197

1299

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

6.8

1593

14053

R01AD12

ATC

fluticasone furoate; nasal

0.8

6.8

677

8205

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

6.7

219

1482

K22

ICPC

Risk factor cardiovascular disease

1.4

6.7

275

1947

A10BX01

ATC

guar gum; systemic

1.5

6.7

242

1672

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

6.7

328

2402

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

0.7

6.7

211

2986

C10AB05

ATC

fenofibrate; oral

1.9

6.7

520

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

3.9

6.6

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

0.8

6.6

662

8029

A02BA02

ATC

ranitidine; systemic

1.2

6.6

1151

9886

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

0.8

6.6

621

7578

A41.9

ICD-10 Finland

Sepsis, unspecified

1.5

6.6

226

1544

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.5

6.6

204

I24.1

ICD-10 Finland

Dressler syndrome

5.1

6.6

I25.40

ICD-10 Finland

Coronary artery aneurysm

7.8

6.6

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.2

6.6

295

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.3

6.6

382

2875

3AC01

NOMESCO Finland

2.3

6.6

244

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.0

6.6

379

A46

ICD-10 Finland

Erysipelas

1.2

6.5

833

6941

H34.2

ICD-10 Finland

Other retinal artery occlusions

2.5

6.5

189

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

1.6

6.5

172

1110

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

1.6

6.5

153

961

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

2.2

6.5

287

L15

ICPC

Knee symptom/complaint

0.8

6.5

605

7388

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.1

6.4

103

K77

ICPC

Heart failure

1.6

6.4

137

839

TK810

NOMESCO Finland

Hemofiltration

2.6

6.4

160

SDA02

NOMESCO Finland

Parodonthologic therapy

0.8

6.4

960

11189

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.4

6.4

204

S97

ICPC

Chronic ulcer skin

1.4

6.3

319

2348

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

2.9

6.3

121

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

6.3

386

2928

I20.02

ICD-10 Finland

Unstable angina

8.1

6.3

R4120

NOMESCO Finland

Occupational therapy

1.4

6.3

269

1926

I21.98

ICD-10 Finland

Myocardial infarction (acute) UNS other occlusion in the coronary artery

5.5

6.3

I20.11

ICD-10 Finland

Angina angiospastic

5.5

6.3

A10BJ06

ATC

semaglutide; parenteral

1.7

6.3

122

726

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.3

6.3

601

4847

J01DA01

ATC

[U] cefalexin; systemic

1.1

6.3

3451

32302

I23.2

ICD-10 Finland

Ventricular septal defect as current complication following acute myocardial infarction

18.0

6.3

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

3.8

6.2

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.4

6.2

236

1649

C10AB04

ATC

gemfibrozil; oral

2.0

6.2

361

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

6.2

501

A69.2

ICD-10 Finland

Lyme disease

0.6

6.2

1449

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.3

6.1

367

2776

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.7

6.1

124

748

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.6

6.1

152

SPAT1104

SPAT

Monitoring of emergency patient

1.4

6.1

335

2501

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

1.6

6.1

129

790

Z50.1

ICD-10 Finland

Other physical therapy

1.4

6.1

255

1819

K92.1

ICD-10 Finland

Melaena

1.4

6.1

328

2446

HMAK

NOMESCO Finland

0.7

6.0

255

3441

SPAT1081

SPAT

Cardiorespiratory global assessment

1.4

6.0

314

2324

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2187

13011

1.95

138.11

6.6

4.1

ng/l

3044.2

445.2

23.14

2050

11247

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1804

10499

1.94

118.80

2.4

2.0

32.5

30.3

22.17

1757

10155

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3136

21685

1.76

117.39

4.0

3.3

ng/l

2592.5

1893.3

7.12

2863

18789

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1280

6748

2.08

110.73

3.1

2.4

ug/l

14.8

7.3

8.71

1147

5756

(3032080) INR in Blood by Coagulation assay

3779

28134

1.68

103.41

11.8

11.4

inr

1.3

1.4

1.67

942

7660

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3352

25594

1.55

73.02

6.4

4.2

ng/l

257.2

78.6

11.11

2809

19977

(3003396) Base excess in Arterial blood by calculation

1334

8388

1.71

63.09

8.4

6.9

mmol/l

0.7

1.1

2.18

1031

6421

(3027801) Oxygen [Partial pressure] in Arterial blood

1325

8406

1.70

60.36

8.5

6.9

kpa

11.5

11.8

1.43

1256

7936

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1325

8408

1.70

60.30

8.5

6.9

kpa

5.0

1.08

1253

7954

(3013826) Glucose [Moles/volume] in Serum or Plasma

4391

36558

1.47

56.96

6.8

5.0

mmol/l

7.4

6.9

25.77

4200

34479

(3016502) Oxygen saturation in Arterial blood

1203

7591

1.69

55.47

8.9

7.3

95.0

95.3

0.80

1159

7272

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1096

6815

1.71

53.18

9.4

7.8

g/l

120.7

121.0

0.15

1060

6565

(3020779) Urea [Moles/volume] in Serum or Plasma

1075

6691

1.71

51.87

9.3

6.9

mmol/l

11.7

11.4

0.52

995

6283

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1386

9400

1.58

47.06

3.2

2.7

19.3

22.0

13.30

1194

7868

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1038

6589

1.67

46.10

4.1

3.1

ng/l

383.1

256.3

5.39

963

6016

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

531

2773

1.98

45.08

3.1

2.9

u/ml

0.3

0.18

323

1604

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1444

9977

1.55

44.94

3.1

2.6

g/l

2.2

0.00

1343

9151

(3000991) Gas panel - Venous blood

928

5839

1.67

42.41

9.9

8.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1512

10694

1.52

41.87

3.1

2.6

umol/l

11.0

12.3

11.26

1414

9789

(3002032) Base excess in Venous blood by calculation

1019

6748

1.59

37.57

4.8

3.8

mmol/l

1.6

1.9

1.09

831

5398

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1020

6767

1.59

37.29

4.8

3.8

kpa

5.8

0.08

982

6544

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

729

4460

1.70

36.77

10.4

8.9

0.7

0.19

722

4420

(3004451) EKG impression Narrative

124

366

3.43

34.81

1.5

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1441

10468

1.46

34.08

3.8

3.2

mmol/l

0.8

0.49

1346

9677

(3019060) Gas panel - Arterial blood

789

5024

1.64

34.01

5.9

4.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1251

8842

1.50

33.96

8.6

7.0

mmol/l

104.7

104.4

0.94

1210

8641

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

719

4475

1.67

33.89

10.0

8.8

1.4

1.11

712

4439

(3014007) Fractional oxyhemoglobin in Arterial blood

718

4468

1.67

33.86

10.6

9.0

93.7

93.8

0.20

718

4444

(3008152) Bicarbonate [Moles/volume] in Arterial blood

745

4694

1.65

33.46

8.3

6.8

mmol/l

24.2

24.4

0.61

699

4378

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

633

3897

1.68

31.01

11.9

9.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2431

19688

1.34

29.51

2.5

2.2

u/l

225.0

241.4

0.56

2273

18376

(3014111) Lactate [Moles/volume] in Serum or Plasma

913

6236

1.53

28.83

8.5

6.7

mmol/l

1.5

1.4

1.08

868

5934

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

609

3823

1.64

27.58

10.7

9.0

mmol/l

23.8

24.3

3.31

555

3502

(3023368) Bacteria identified in Blood by Culture

2454

20096

1.33

27.02

5.1

4.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

817

5545

1.53

26.46

3.9

3.2

kpa

4.5

0.27

782

5332

(3004119) Hemoglobin [Mass/volume] in Venous blood

658

4383

1.55

23.10

4.3

3.4

g/l

124.7

128.1

3.35

640

4275

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

523

3317

1.62

22.65

5.2

3.9

mmol/l

23.5

24.0

2.92

470

2956

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

608

4000

1.56

22.54

9.2

7.2

mmol/l

24.4

24.8

1.52

603

3953

(3020682) Albumin/Creatinine [Ratio] in Urine

2505

20978

1.29

22.28

4.2

4.0

mg/mmol

15.0

10.0

3.44

1667

13745

(3033658) Prothrombin time (PT) actual/Normal

1871

15175

1.31

20.96

5.2

4.2

81.5

82.6

1.01

1822

14805

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3591

31572

1.26

20.96

6.6

6.3

umol/l

12.6

12.7

0.27

3422

29887

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2058

16906

1.30

20.95

2.5

2.3

mg/l

3.2

3.1

1.32

1754

14218

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1177

8927

1.38

20.73

7.5

5.8

mmol/l

1.1

1.0

3.96

1083

8218

(3012516) Albumin [Mass/volume] in Urine

2358

19831

1.27

19.67

3.4

3.3

mg/l

399.4

360.9

0.17

1624

13159

(40768804) Tissue Pathology biopsy report

1812

21909

0.77

19.33

2.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

412

2566

1.64

19.18

3.1

2.3

ug/l

575.4

683.0

0.32

395

2437

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2338

27378

0.79

19.08

4.2

4.6

23.0

22.1

1.72

1181

14262

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2097

17486

1.27

18.52

3.2

u/l

41.1

37.0

0.96

1970

16429

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1502

12042

1.31

17.92

2.2

1.7

mg/l

1.6

1.5

0.43

1223

9417

(3024928) Oxygen saturation in Venous blood

259

1450

1.81

17.73

4.1

2.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1605

19536

0.77

17.67

3.0

3.2

ug/l

0.8

0.42

1174

13765

(3018405) Lactate [Moles/volume] in Arterial blood

409

2604

1.60

17.42

4.6

4.0

mmol/l

1.5

1.4

0.56

398

2559

(3028626) Oxygen [Partial pressure] in Capillary blood

287

1682

1.73

16.82

3.5

2.8

kpa

7.6

7.8

1.32

271

1542

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

464

3073

1.54

16.65

6.6

5.0

1.8

1.6

2.50

444

2876

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3045

34297

0.81

16.47

4.7

5.3

ug/l

3.2

3.8

0.62

2656

30471

(3043409) Potassium [Moles/volume] in Arterial blood

353

2201

1.63

16.38

5.0

4.3

mmol/l

3.9

0.15

324

2050

(3021901) Oxygen saturation in Capillary blood

254

1450

1.78

16.32

3.7

2.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

455

3023

1.54

16.09

6.6

5.0

0.9

0.28

433

2830

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

180

3.30

15.93

7.3

7.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

151

3.53

15.91

7.1

7.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

272

1610

1.71

15.41

2.9

2.4

g/l

3.5

3.6

0.82

261

1518

(3027273) Bicarbonate [Moles/volume] in Venous blood

526

3641

1.48

15.28

4.3

3.6

mmol/l

25.2

25.1

0.40

512

3523

(3009508) Creatinine [Moles/volume] in Urine

2339

20105

1.24

15.18

3.3

3.2

mmol/l

7.4

7.7

2.75

1924

16508

(3044640) Blood type and Crossmatch panel - Blood

2236

19172

1.23

14.76

2.9

2.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1027

8033

1.32

14.36

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

314

1967

1.62

14.33

4.0

3.0

mmol/l

24.5

24.7

0.28

285

1707

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

465

3188

1.49

14.17

2.1

1.9

ug/l

1.7

2.4

1.24

423

2757

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

134

3.52

14.13

1.1

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3064

27225

1.21

13.99

4.6

4.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1422

11650

1.27

13.91

2.0

1.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

873

6701

1.34

13.88

2.8

2.7

umol/l

9.5

10.1

0.31

767

5886

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

476

3311

1.47

13.49

3.3

2.7

0.7

0.29

466

3168

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1015

8021

1.31

13.11

1.9

1.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

474

3366

1.44

12.05

5.3

4.2

45.8

47.8

1.02

467

3324

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

251

1557

1.63

11.97

2.8

2.2

83.9

86.9

1.15

241

1475

(3006576) Bicarbonate [Moles/volume] in Blood

278

2.53

11.82

7.1

6.5

mmol/l

25.6

24.8

1.10

248

(3002582) Erythrocytes [#/volume] in Urine

2292

20097

1.20

11.42

3.7

3.5

e6/l

171.0

114.7

0.75

1836

15907

(3000963) Hemoglobin [Mass/volume] in Blood

5725

59880

0.83

11.31

35.4

25.8

g/l

132.5

134.7

18.70

5624

58651

(3035941) MCH [Entitic mass]

5724

59865

0.83

11.26

35.0

25.5

30.4

30.5

3.55

5612

58634

(3026361) Erythrocytes [#/volume] in Blood

5725

59872

0.83

11.24

35.1

25.6

e12/l

4.4

8.14

5523

57704

(3024731) MCV [Entitic volume]

5725

59869

0.83

11.22

35.0

25.6

91.8

0.70

5615

58636

(3010813) Leukocytes [#/volume] in Blood

5728

59883

0.83

11.09

35.2

25.7

e9/l

7.6

7.0

17.66

5532

57727

(3007461) Platelets [#/volume] in Blood

5725

59853

0.83

11.08

35.1

25.6

e9/l

232.2

234.9

2.26

5543

57927

(3023183) Ammonium ion [Moles/volume] in Plasma

231

1437

1.63

10.93

2.6

2.5

umol/l

32.4

34.3

0.60

190

1169

(3022217) INR in Platelet poor plasma by Coagulation assay

1270

10534

1.25

10.92

29.7

29.9

inr

1.5

0.20

168

1417

(3027945) Reticulocytes/100 erythrocytes in Blood

1075

8755

1.26

10.83

2.4

1.9

1.8

2.66

955

7592

(3036489) Thrombin time

299

1981

1.53

10.79

2.6

2.0

22.5

21.8

0.84

273

1783

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2507

22248

1.19

10.78

3.5

2.9

ug/l

170.6

178.2

0.47

2308

20035

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

227

1412

1.63

10.75

3.0

2.5

226.3

205.9

2.52

221

1335

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

501

3669

1.39

10.70

1.6

g/l

1.7

1.5

2.62

428

3098

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

251

1602

1.59

10.69

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

251

1602

1.59

10.69

1.4

1.3

—

(3020891) Body temperature

405

2870

1.43

10.44

5.7

4.9

—

(3030467) Casts [#/volume] in Urine by Automated count

2083

18241

1.19

10.31

3.6

3.4

e6/l

0.7

0.5

1.80

1637

14137

(3039000) Anion gap in Blood

253

1633

1.57

10.28

8.9

6.6

mmol/l

11.9

11.3

1.41

234

1457

(3018572) Chloride [Moles/volume] in Blood

253

1633

1.57

10.28

8.9

6.6

mmol/l

105.1

0.06

234

1457

(3052851) Hemolysis interference index of Serum or Plasma

289

1933

1.51

10.00

4.3

3.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

162

942

1.74

9.93

6.1

6.5

mg/l

12.0

11.9

0.08

152

850

(3000850) Epithelial cells [#/volume] in Urine

1654

14223

1.21

9.91

3.0

2.7

e6/l

4.6

3.9

1.76

1475

12478

(1616796) Gas panel - Central venous blood

255

1665

1.55

9.86

5.0

3.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

905

7300

1.27

9.83

2.0

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

633

4871

1.33

9.83

1.7

1.6

—

(3018095) Leukocytes [#/volume] in Urine

2492

22281

1.18

9.51

4.2

4.0

e6/l

110.1

114.4

0.07

1925

16811

(3042733) HLA Ab [Presence] in Serum

160

2.82

9.50

4.3

4.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

610

4712

1.32

9.22

4.5

3.7

kpa

5.1

1.42

567

4302

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

125

3.05

9.21

8.4

7.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

149

869

1.73

9.07

14.1

15.6

mmol/l

8.0

7.6

0.71

123

704

(3047181) Lactate [Moles/volume] in Blood

322

2248

1.45

9.03

8.1

5.9

mmol/l

1.5

1.3

1.24

294

1987

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

583

4502

1.32

8.83

4.5

3.6

mmol/l

1.6

1.8

0.27

422

3250

(3017817) Protein [Mass] in Urine collected for unspecified duration

117

643

1.83

8.73

1.7

2.3

—

0.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

155

925

1.69

8.70

1.4

—

(3009343) pH of Capillary blood

598

4651

1.31

8.61

4.5

3.7

7.4

0.19

563

(36304419) Bacteria [Presence] in Urine

1968

17405

1.18

8.37

3.6

3.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

201

2.50

8.35

34.4

32.6

ug/l

7.7

7.3

0.64

178

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2132

18987

1.17

8.30

2.9

2.6

u/l

58.1

59.3

0.39

1985

17498

(40767503) Oxygen content in Capillary blood by calculation

236

1581

1.51

8.18

3.4

2.5

15.3

15.9

1.64

134

824

(3008037) Lactate [Moles/volume] in Venous blood

253

1722

1.49

8.12

4.7

3.5

mmol/l

1.6

1.7

1.78

248

1681

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3110

28535

1.15

8.06

8.4

6.3

mmol/l

1.2

9.16

2860

25584

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

598

4709

1.29

7.85

5.0

3.9

ng/l

128.9

100.5

6.86

527

3974

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3396

31397

1.15

7.80

9.2

7.0

mmol/l

1.2

13.33

2928

26184

(3051651) Icteric interference index of Serum or Plasma

378

2.02

7.67

5.2

4.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

668

5354

1.27

7.62

2.7

2.4

u/l

41.5

46.5

0.22

585

4562

(3024561) Albumin [Mass/volume] in Serum or Plasma

2991

27447

1.15

7.59

5.6

4.9

g/l

33.6

34.4

11.32

2777

25236

(3024891) Influenza virus A+B Ag [Presence] in Specimen

205

1356

1.53

7.57

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5603

58195

0.86

7.43

29.4

20.9

umol/l

95.5

87.8

21.32

5598

58171

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

541

4239

1.30

7.39

1.6

1.5

—

(3027315) Oxygen [Partial pressure] in Blood

242

1674

1.46

7.20

5.7

4.5

kpa

8.3

8.4

0.25

236

1627

(3006184) Hemoglobin [Mass/volume] in Capillary blood

237

1633

1.47

7.20

2.9

2.2

g/l

125.4

127.5

0.56

187

1195

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

190

2824

0.66

7.15

2.1

1.9

—

(3012501) Base excess in Blood by calculation

241

1669

1.46

7.13

5.7

4.5

mmol/l

2.7

2.6

0.12

154

1115

(42870588) Differential panel, method unspecified - Blood

2220

20017

1.15

7.12

6.1

5.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

615

4921

1.27

7.12

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

241

1670

1.46

7.11

5.7

4.5

kpa

5.0

0.04

235

1624

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

399

1.94

6.96

1.2

1.1

titre

152.4

135.4

0.08

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5591

57997

0.87

6.91

13.4

11.1

u/l

28.2

26.5

4.37

5379

55417

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

6.01

6.90

3.8

12.6

—

(3026782) Osmolality of Urine

1531

13454

1.17

6.86

3.2

3.0

mosm/kgh2o

559.5

567.4

0.79

1335

11488

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

103

1743

0.59

6.86

1.6

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

546

4328

1.28

6.83

1.7

—

(3044889) 12 lead EKG panel

4303

40630

1.13

6.75

5.7

4.3

—

(21494755) Public health laboratory ask at order entry panel

167

2517

0.66

6.75

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1226

10595

1.19

6.71

3.1

3.3

e6/l

2.4

1.6

2.13

722

6154

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

176

1159

1.53

6.69

1.5

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1289

11197

1.18

6.63

3.0

e6/l

1.2

1.1

0.62

769

6703

(3022096) Basophils/100 leukocytes in Blood

2814

25895

1.14

6.57

6.5

5.8

0.6

2.64

2616

23904

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1652

14661

1.16

6.48

2.9

2.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

160

1044

1.54

6.36

1.5

1.4

—

(40758558) Short blood count panel - Blood

1600

14191

1.16

6.31

7.3

6.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

158

1032

1.54

6.26

3.3

2.5

—

(3011648) Oxygen content in Venous blood

480

1.80

6.23

1.8

1.9

10.1

11.0

0.97

480

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

253

1816

1.41

6.21

2.5

2.3

ug/min

118.6

121.2

0.04

160

1076

(3006315) Basophils [#/volume] in Blood

3053

28311

1.13

6.20

6.3

5.5

e9/l

0.0

0.66

2583

24129

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

173

1162

1.50

6.03

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1881

16938

1.15

5.97

3.1

3.0

umol/l

5982.8

5656.3

0.10

1612

14403

(3039443) Prostate specific Ag panel - Serum or Plasma

1451

0.58

5.91

1.6

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

240

1724

1.40

5.89

1.6

1.3

iu/ml

16.1

13.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

353

2695

1.32

5.88

1.5

u/ml

5.9

21.0

—

(3010421) pH of Blood

262

1912

1.38

5.86

5.6

4.4

7.4

0.07

236

1625

(3026008) Bacteria identified in Urine by Culture

2032

18418

1.14

5.83

3.6

3.4

—

(3006504) Eosinophils/100 leukocytes in Blood

2871

26599

1.13

5.81

6.6

5.8

2.9

0.04

2667

24524

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

349

1.90

5.70

1.3

1.4

umol/l

17.2

14.6

1.25

327

(3019069) Monocytes/100 leukocytes in Blood

2882

26732

1.13

5.68

7.0

6.1

9.0

0.04

2680

24721

(3001604) Monocytes [#/volume] in Blood

3023

28130

1.12

5.63

6.3

5.5

e9/l

0.7

0.6

16.10

2556

23925

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

145

953

1.53

5.63

1.5

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

571

1.69

5.61

1.1

1.2

u/l

103.7

67.1

0.29

368

(3023520) Reticulocytes [#/volume] in Blood

783

6625

1.20

5.40

2.4

2.5

e9/l

72.8

67.7

2.66

580

5120

(3019198) Lymphocytes [#/volume] in Blood

3087

28814

1.12

5.37

6.4

5.6

e9/l

1.9

0.03

2666

24923

(3051611) Lipemic interference index of Serum or Plasma

110

689

1.61

5.29

4.7

3.7

—

(3000330) Specific gravity of Urine by Test strip

430

3422

1.27

5.27

4.3

3.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

284

2140

1.34

5.22

1.3

—

(3002256) Pathology report gross observation

647

7715

0.82

5.21

1.3

1.4

—

(3013115) Eosinophils [#/volume] in Blood

3121

29192

1.12

5.18

6.4

5.7

e9/l

0.2

2.85

2710

25150

(3042936) Bacteria identified in Isolate by Culture

1059

9236

1.17

5.13

2.4

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

191

2656

0.71

5.10

1.4

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.63

4.97

11.7

12.4

mmol/l

5.2

5.5

0.29

(3017143) Hepatitis C virus Ab [Presence] in Serum

546

4497

1.23

4.96

1.7

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

288

1.92

4.94

9.1

5.6

mg/l

3749.7

99.3

0.48

199

(3002030) Lymphocytes/100 leukocytes in Blood

2916

27226

1.11

4.92

6.8

6.0

23.6

25.6

17.61

2693

25011

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

354

1.81

4.86

1.2

mmol/l

13.3

11.7

0.64

126

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

140

945

1.49

4.85

1.6

1.5

—

(40768800) Prostate Pathology biopsy report

157

2231

0.70

4.78

1.1

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

483

1.68

4.76

1.6

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

471

5733

0.81

4.66

2.0

2.1

nmol/l

11.4

12.3

1.39

394

4983

(46235355) HIV 1 and 2 tests - Meaningful Use set

646

5445

1.20

4.66

1.6

1.5

—

(3024932) HLA-DR beta [Type]

152

2.24

4.64

1.0

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

2861

26749

1.11

4.63

6.6

5.7

60.8

58.9

13.35

2652

24712

(4094501)

211

1550

1.37

4.62

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

339

1.81

4.59

1.5

1.6

u/l

5.4

6.9

0.28

153

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

123

819

1.51

4.57

1.5

u/ml

115.0

120.1

0.22

166

(3013512) EKG study

2063

18965

1.12

4.52

6.3

4.4

—

(3021589) Normoblasts [#/volume] in Blood

2623

24441

1.11

4.49

12.7

10.5

e9/l

0.0

0.93

2107

19934

(3023419) Bacteria identified in Sputum by Culture

131

888

1.48

4.48

2.3

2.4

—

(3024471) HLA-A [Type]

156

2.18

4.38

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

244

1.93

4.37

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

965

8461

1.16

4.36

3.9

4.0

u/l

268.5

247.2

2.33

913

7918

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

116

772

1.51

4.35

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

166

1185

1.41

4.33

1.2

1.3

u/l

33.5

39.8

0.39

150

1011

(3016750) Collection duration of Urine

421

1.69

4.30

2.2

2.0

min

516.7

493.2

1.11

298

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

163

1164

1.41

4.25

1.5

1.4

nmol/l

1.0

0.8

1.14

124

960

(3018418) pH of Serum or Plasma

1999

18405

1.12

4.22

5.0

4.1

7.4

0.41

374

3599

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

164

1175

1.40

4.20

1.6

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

191

1406

1.37

4.16

1.7

1.4

g/l

1.2

1.00

176

1326

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

588

1.57

4.15

1.6

1.5

—

(3000492) Spirometry study

545

4575

1.21

4.13

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

206

1538

1.35

4.11

1.6

—

(3022313) Gas panel - Capillary blood

412

3373

1.23

4.01

4.5

3.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3439

32618

1.10

3.99

8.8

8.6

e9/l

4.9

4.4

24.61

2941

28194

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

184

1357

1.36

3.98

1.7

1.4

g/l

0.3

0.2

2.04

171

1280

(40761511) CBC panel - Blood by Automated count

5455

56122

0.90

3.95

23.4

17.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

114

773

1.48

3.94

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

112

757

1.49

3.93

3.4

3.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

123

1758

0.69

3.93

1.6

1.8

nmol/l

41.3

43.4

0.50

114

1678

(3004775) Volume in Urine collected for unspecified duration

613

1.54

3.91

2.6

2.1

656.7

642.9

0.11

385

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

551

4658

1.20

3.89

1.7

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

212

1605

1.33

3.87

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1550

14134

1.12

3.85

1.8

1.6

mmol/l

1.4

1.3

1.55

1301

11623

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

134

947

1.42

3.75

1.5

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

177

1311

1.36

3.75

1.1

1.2

titre

1018.0

1025.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

573

4881

1.19

3.72

3.5

2.8

ml/min/173m2

51.4

61.2

8.73

261

2057

(3027456) Digoxin [Moles/volume] in Serum or Plasma

225

1731

1.31

3.69

3.1

nmol/l

0.8

0.10

176

1286

(3020630) Protein [Mass/volume] in Serum or Plasma

702

6094

1.17

3.63

2.1

2.5

g/l

64.8

66.0

3.91

631

5438

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

213

1634

1.31

3.58

3.3

2.6

mg/l

2.1

1.7

5.42

188

1454

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

382

1.65

3.57

2.6

2.1

ug/min

238.7

165.1

0.22

(3007566) Smooth muscle Ab [Titer] in Serum

177

1325

1.34

3.53

1.1

1.2

titre

73.1

142.9

1.45

101

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.44

3.33

4.4

3.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

296

2393

1.25

3.30

3.3

3.2

pmol/l

4.3

4.4

0.17

263

2075

(3019977) pH of Arterial blood

447

1.57

3.25

2.2

2.3

7.4

1.10

166

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

297

2406

1.24

3.25

1.9

3.1

ratio

2.7

3.3

0.20

177

(3003434) Protein [Mass/volume] in Pleural fluid

166

1248

1.34

3.25

1.6

1.5

g/l

28.7

31.6

2.18

147

1101

(3019309) Folate [Moles/volume] in Red Blood Cells

1544

14201

1.11

3.24

1.9

1.8

nmol/l

1097.2

1150.3

1.52

1213

10521

(3052592) Norovirus Ag [Presence] in Stool

149

2.02

3.24

1.7

1.4

—

(4306422)

585

1.49

3.21

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

241

1912

1.27

3.17

1.8

2.3

g/l

0.0

0.00

216

1732

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

303

2468

1.24

3.17

1.9

3.1

mg/l

37.3

58.3

2.48

243

1983

(3021879) Hepatitis B virus core Ab [Presence] in Serum

348

2876

1.22

3.17

1.3

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

482

1.54

3.17

1.3

1.1

—

(4035726)

439

5172

0.84

3.16

1.5

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

110

777

1.42

3.15

1.4

2.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

671

5877

1.16

3.12

2.2

g/l

0.2

0.27

616

5393

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4722

48692

0.92

3.06

4.6

4.3

mu/l

2.1

2.2

0.78

4239

43289

(3034860) Kappa light chains.free [Mass/volume] in Serum

302

2472

1.23

3.03

1.9

3.1

mg/l

72.7

87.0

0.21

243

1984

(3036525) Urea [Moles/time] in 24 hour Urine

2.89

3.02

3.0

3.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4652

45022

1.08

3.01

8.6

7.7

u/l

85.2

81.3

3.07

4390

42151

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

491

0.51

3.00

1.2

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

417

1.56

2.99

1.7

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

696

6134

1.15

2.97

1.3

titre

548.3

463.7

0.60

164

1242

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

234

1.76

2.95

2.8

2.3

102.6

93.0

0.86

223

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.71

2.91

6.4

5.7

umol/l

345.1

414.9

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

326

1.63

2.91

1.2

1.3

u/l

137.0

95.4

0.97

269

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2492

26329

0.92

2.91

2.4

2.3

—

(3022145) Colonoscopy Study observation

544

6252

0.86

2.91

1.4

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

149

1123

1.33

2.91

7.1

5.4

iu/ml

5854.8

1868.1

0.34

179

(3023420) DNA double strand Ab [Units/volume] in Serum

405

1.56

2.89

1.8

1.2

iu/ml

61.3

24.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

258

2089

1.24

2.88

1.8

2.2

g/l

0.0

0.1

1.61

233

1876

(1761482) Bacteria [#/volume] in Urine by Culture

250

2020

1.25

2.85

5.5

4.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

594

1.45

2.82

1.3

—

(3019225) pH of Specimen

571

6523

0.87

2.82

5.2

4.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

121

888

1.37

2.82

1.2

1.3

—

(3017569) Oxygen content in Arterial blood

384

1.57

2.81

2.3

2.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1095

0.68

2.80

1.6

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

314

1.63

2.80

1.2

1.3

u/l

49.1

25.2

1.04

256

(3034274) Bile acid [Moles/volume] in Serum --fasting

172

1.86

2.80

1.1

1.3

umol/l

6.8

18.2

1.11

114

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

241

1945

1.25

2.78

1.8

2.2

g/l

0.0

1.04

216

1740

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

417

1.54

2.78

1.7

1.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

5.00

2.72

10.4

10.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

218

1.75

2.71

2.4

2.0

umol/l

62.2

111.8

2.11

119

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

616

1.43

2.70

1.2

u/ml

8.4

4.0

0.68

292

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

266

2183

1.23

2.65

1.8

2.2

g/l

35.9

37.2

3.13

227

1833

(3023103) Potassium [Moles/volume] in Serum or Plasma

5705

58243

0.92

2.63

30.7

21.3

mmol/l

4.1

4.0

25.54

5571

56549

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5005

51363

0.93

2.63

23.1

16.9

ml/min/173m2

70.9

73.4

11.96

4252

42947

(3022621) pH of Urine by Test strip

461

3989

1.17

2.56

3.0

3.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

322

1.59

2.56

1.5

1.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

181

1429

1.27

2.55

3.7

mg/l

31.2

30.8

0.05

127

940

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

317

2660

1.20

2.53

1.7

2.2

g/l

10.2

10.3

0.30

266

2204

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

336

2841

1.19

2.48

1.7

2.2

g/l

3.8

0.09

244

1988

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

114

850

1.35

2.45

3.0

2.5

u/ml

1341.2

2067.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

209

1689

1.24

2.43

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

336

2850

1.19

2.40

1.7

2.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

312

2630

1.19

2.39

1.7

2.3

g/l

3.3

3.1

3.15

245

2025

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

336

2851

1.19

2.39

1.7

2.2

g/l

7.8

7.4

3.57

249

2059

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

227

1.68

2.39

1.9

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

227

1.68

2.39

1.9

2.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

254

2102

1.22

2.37

1.6

1.5

titre

109.1

216.5

1.28

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.61

2.35

1.0

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5702

58121

0.93

2.29

30.4

21.1

mmol/l

139.4

139.6

5.71

5573

56506

(40768443) Skin Pathology biopsy report

217

2640

0.82

2.29

1.3

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

429

1.47

2.28

1.2

1.3

promille

1.2

1.3

0.08

333

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

579

1.40

2.27

1.1

108.8

111.4

0.28

516

(3044242) Glucose [Moles/volume] in Arterial blood

390

1.49

2.24

1.7

2.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

2.24

0.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

2.23

0.0

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

468

0.58

2.22

1.2

1.4

pmol/l

47.0

125.0

0.65

148

(40768795) Lymph node Pathology biopsy report

543

0.61

2.22

1.2

—

(3001729) Color of Synovial fluid

2.34

2.21

1.5

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.78

2.20

1.7

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

148

1865

0.79

2.17

1.0

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

257

1.60

2.17

1.5

1.4

22.1

19.5

0.24

234

(3004588) Protein electrophoresis panel - Serum or Plasma

569

5064

1.13

2.16

1.9

2.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

770

6980

1.11

2.15

4.4

3.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1255

0.75

2.14

2.8

1.7

mg/l

3.8

4.1

0.12

906

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2778

26597

1.07

2.14

2.2

2.1

pmol/l

91.3

91.9

0.26

1550

14544

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

104

783

1.33

2.14

1.0

1.1

iu/ml

5.2

278.2

0.74

158

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

663

1.36

2.13

1.3

nmol/l

0.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

110

836

1.32

2.12

1.4

mmol/l

6.9

6.4

0.90

100

756

(3002331) Protein [Mass/volume] in Peritoneal fluid

152

1.78

2.11

1.3

1.4

g/l

26.6

26.7

0.02

115

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

2.05

2.10

1.1

1.2

—

11.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

265

3132

0.84

2.08

1.2

—

(3006270) Folate [Moles/volume] in Blood

590

1.38

2.07

1.2

nmol/l

308.4

324.5

0.26

451

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

128

1000

1.28

2.03

1.2

—

(40768806) Pleura Pathology biopsy report

123

956

1.29

2.03

1.5

1.6

—

(3045788) Cell count panel - Pleural fluid

110

843

1.31

2.02

1.6

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

286

1.54

2.02

1.0

1.1

u/l

94.4

99.0

0.14

219

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

101

766

1.32

2.00

1.2

u/ml

298.0

300.0

0.02

477

(3035880) pH of Pleural fluid

501

1.40

1.99

1.4

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

287

1.54

1.99

1.1

u/l

23.6

32.7

0.73

211

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

683

7529

0.90

1.97

5.7

4.8

33.3

32.6

0.92

556

4960

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

281

2396

1.18

1.95

1.8

2.4

g/l

0.7

1.1

1.20

237

2009

(40760888) Immunoglobulin light chains.free panel - Serum

225

1881

1.20

1.95

1.9

3.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

370

1.46

1.95

1.0

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

354

1.47

1.94

1.6

1.4

60.3

66.9

0.75

283

(3044941) Cell count panel - Synovial fluid

125

981

1.28

1.93

1.4

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

2.45

1.92

1.1

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

320

2764

1.16

1.90

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

215

1795

1.20

1.90

1.4

—

(3033799) Differential panel - Peritoneal fluid

228

1.58

1.86

1.5

1.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.09

1.86

1.7

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

238

2801

0.84

1.82

1.2

1.3

au/ml

27.4

59.3

—

110

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

844

9166

0.91

1.82

1.2

u/ml

2.0

0.07

183

2305

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

145

1.73

1.80

1.7

1.5

20.4

7.0

1.34

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

254

1.54

1.80

2.0

1.9

u/l

2.6

145.5

0.81

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

360

1.45

1.80

1.4

2.0

u/field

3.9

2.3

0.60

248

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

167

2025

0.82

1.78

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

186

1543

1.21

1.78

1.4

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

105

819

1.29

1.74

1.4

1.3

—

(4062490)

498

1.37

1.73

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

636

1.32

1.72

1.2

u/ml

1.8

3.5

1.74

210

(3006922) Hepatitis E virus Ab [Presence] in Serum

314

1.47

1.72

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

189

1576

1.20

1.72

1.3

1.2

u/ml

1.7

0.6

0.41

140

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

611

1.33

1.71

1.7

2.2

u/field

1.7

0.02

217

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

735

8007

0.91

1.70

11.8

8.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

382

1.42

1.69

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1072

0.76

1.68

1.3

1.4

e6/l

1041.5

908.6

0.11

872

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

2.03

1.64

2.0

1.6

au/ml

35.4

86.9

—

(3012441) Differential panel - Pleural fluid

121

969

1.25

1.63

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

393

1.40

1.63

3.5

2.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

496

1.35

1.61

1.2

1.4

g/l

2.6

3.1

2.22

350

(3024139) IgG subclass 3 [Mass/volume] in Serum

496

1.35

1.61

1.2

1.4

g/l

0.4

0.5

1.02

347

(3027135) IgG subclass 1 [Mass/volume] in Serum

496

1.35

1.61

1.2

1.4

g/l

6.7

7.2

0.45

345

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

251

0.52

1.61

6.1

6.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.57

1.61

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.57

1.61

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

224

0.49

1.60

1.0

1.1

—

(44790048)

688

1.30

1.60

1.5

1.4

—

(44790049)

688

1.30

1.60

1.5

1.4

—

(44790047)

688

1.30

1.60

1.5

1.4

—

(44806118)

688

1.30

1.60

1.5

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

104

1309

0.79

1.60

1.7

1.9

pmol/l

196.8

200.1

0.14

1209

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3757

38592

0.95

1.58

3.7

3.5

pmol/l

15.1

15.0

0.29

3366

34109

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.00

1.58

1.0

1.3

u/field

1.3

0.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1071

0.77

1.56

1.3

e6/l

32.6

21.9

0.21

827

(4024509)

578

0.69

1.56

1.8

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

160

1.63

1.55

1.0

1.1

103.1

94.2

0.71

125

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

109

869

1.26

1.55

1.4

1.3

u/l

448.3

376.3

0.20

103

818

(3017732) Neutrophils [#/volume] in Blood

328

3714

0.88

1.54

3.9

3.3

e9/l

4.7

4.2

2.24

228

2659

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5254

53459

0.94

1.53

5.8

5.1

mmol/l

6.5

6.1

35.77

4775

47564

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

1.52

0.0

1.5

—

0.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

1.52

0.0

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5271

51773

1.06

1.51

8.2

6.6

mmol/mol

43.8

41.2

52.25

4910

46972

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

443

0.65

1.50

1.0

ng/l

749.4

696.6

0.21

285

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

443

0.65

1.50

1.0

ng/l

52.3

42.7

0.41

287

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

341

3018

1.14

1.50

2.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

299

1.44

1.50

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

299

1.44

1.50

1.1

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

210

1794

1.18

1.50

1.4

1.5

—

(4034850)

216

1850

1.17

1.49

15.1

12.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

234

1.50

1.48

24.5

26.9

ug/l

100.7

111.6

0.65

197

(4198724)

101

1.78

1.48

1.3

1.5

—

(3020491) Glucose [Moles/volume] in Blood

444

1.35

1.47

2.1

mmol/l

7.4

7.2

0.32

299

(3036481) Cortisol [Moles/volume] in Serum or Plasma

510

4628

1.11

1.47

2.4

2.3

nmol/l

396.3

375.5

0.60

463

4207

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

251

1.48

1.47

2.2

2.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

440

0.66

1.46

1.0

ng/l

412.5

312.1

0.62

291

(3019150) Specific gravity of Urine by Refractometry

1321

12485

1.07

1.46

4.7

4.3

kg/l

1.0

0.38

247

1938

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

122

993

1.23

1.46

5.0

3.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

403

0.64

1.45

1.3

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

293

1.44

1.45

1.6

1.4

2.2

2.6

0.13

245

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

646

1.29

1.45

1.4

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

968

0.77

1.44

1.2

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

273

3112

0.87

1.44

2.2

2.4

au/ml

39.7

25.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4033

41288

0.95

1.44

4.5

4.1

mm/h

16.0

14.1

9.26

3720

37622

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

745

1.26

1.42

1.2

u/ml

51.2

43.9

0.16

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

180

0.50

1.38

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

695

1.27

1.38

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

120

982

1.23

1.38

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

214

1.50

1.37

1.2

ratio

1.1

0.40

(3039162) Centromere protein B Ab [Units/volume] in Serum

485

1.32

1.37

1.2

u/ml

25.2

54.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

174

1.55

1.36

1.3

1.1

u/ml

2.0

10.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

4678

47678

0.95

1.36

26.6

18.9

38.1

39.1

5.83

2931

29768

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

1.33

0.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

128

1.64

1.32

1.4

1.5

ug/l

10.2

9.7

0.16

128

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.78

1.32

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.97

1.32

1.8

2.0

mmol/l

0.9

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

163

1381

1.18

1.32

1.8

mg/l

11.3

12.5

0.90

151

1272

(40768446) Kidney Pathology biopsy report

200

1.50

1.31

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

156

1318

1.19

1.31

2.2

2.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

217

1.48

1.30

1.6

2.0

e6/l

22759.6

15602.0

0.16

129

(3002619) Bacteria identified in Specimen by Culture

114

1.67

1.28

1.6

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

590

1.27

1.24

1.2

1.3

nmol/l

—

(40768793) Breast Pathology biopsy report

620

0.74

1.24

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.40

1.24

1.2

nmol/l

219.4

269.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.22

1.24

1.4

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

228

1.45

1.23

1.2

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

103

842

1.23

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

452

4948

0.91

1.22

1.2

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

351

3160

1.12

1.22

1.5

1.8

g/l

1.2

1.4

1.74

320

2806

(3028308) Erythrocytes [#/volume] in Pleural fluid

121

1007

1.20

1.21

1.5

e6/l

154376.7

58023.3

0.74

600

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3283

33683

0.96

1.21

3.7

3.2

u/l

67.8

58.1

3.79

3023

30650

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

116

1.64

1.21

1.1

1.3

85.1

89.2

0.20

104

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.75

1.18

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

639

1.25

1.18

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

595

1.26

1.18

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.93

1.16

1.6

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

794

1.22

1.16

1.7

1.6

g/l

0.9

0.08

609

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

615

1.25

1.15

1.4

1.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

142

1.55

1.14

1.2

1.0

—

(3000494) Fungus identified in Specimen by Culture

612

6580

0.92

1.12

1.5

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.96

1.11

1.3

2.0

26.0

16.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.96

1.11

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

131

1110

1.18

1.10

1.5

e6/l

812.3

1999.1

4.27

800

(3012565) Volume of 24 hour Urine

302

1.36

1.10

2.2

2.5

1744.7

1870.5

0.34

247

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

285

1.37

1.10

1.3

1.2

—

(3008295) Osmolality of Serum or Plasma

627

0.76

1.08

1.2

1.3

mosm/kgh2o

282.6

279.5

0.42

465

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

163

0.55

1.08

1.1

—

(3017704) Immunofixation for Urine

425

1.30

1.08

1.3

1.5

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.19

1.08

1.0

—

2.7

—

(3024263) Appearance of Synovial fluid

364

1.32

1.07

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

748

1.22

1.06

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

121

0.50

1.05

1.3

mu/l

99.0

64.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

392

1.30

1.04

1.1

—

(3022689) Creatine [Moles/volume] in Urine

162

1.48

1.03

1.3

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1387

13278

1.05

1.03

3.9

3.8

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.06

1.02

1.4

pmol/l

17.8

23.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

120

1409

0.85

1.02

2.6

3.3

u/ml

1168.0

851.4

0.17

108

1298

(40762365) Oxygen content in Arterial blood by calculation

155

1.49

1.00

3.5

2.8

ml/dl

15.5

14.7

0.66

143

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

115

1.57

0.99

1.1

1.2

81.1

81.7

0.03

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

297

0.67

0.99

5.4

3.8

u/ml

190.6

47.4

0.41

292

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.84

0.98

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

266

1.35

0.97

1.5

2.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

177

1555

1.14

0.97

1.6

1.5

e6/l

13425.9

17436.7

0.58

122

1103

(3025315) Body weight

1.80

0.96

5.8

4.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

116

1.55

0.96

1.1

1.3

74.5

79.2

0.19

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

302

1.33

0.95

1.3

1.4

u/l

13.1

6.1

0.81

253

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

230

2058

1.12

0.95

1.9

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

687

1.21

0.94

1.3

u/l

11.4

13.9

0.74

624

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.61

0.93

1.1

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

109

1.56

0.93

1.5

—

(3044927) Protein electrophoresis panel - Urine

780

1.19

0.92

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

142

1.48

0.92

1.2

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

278

1.33

0.91

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

278

1.33

0.91

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

278

1.33

0.91

1.2

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

313

2855

1.10

0.91

5.1

4.1

mmol/l

24.3

24.8

1.72

288

2570

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

287

1.33

0.91

1.2

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

718

1.20

0.90

1.0

1.1

g/l

1.7

1.5

2.17

648

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

156

1368

1.14

0.89

1.9

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5143

50762

1.04

0.89

5.4

4.2

mmol/l

1.4

1.3

8.42

4739

45248

(3045683) HLA typing for celiac disease panel - Blood or Tissue

182

0.60

0.89

1.0

—

(4010399)

435

4033

1.08

0.88

1.5

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

135

1.48

0.88

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

403

1.27

0.88

2.2

2.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

245

1.35

0.88

4.3

2.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

152

0.59

0.88

1.3

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

123

1063

1.16

0.87

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

703

1.20

0.86

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

112

1300

0.86

1.9

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

640

1.21

0.85

1.4

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

128

1.49

0.85

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

481

0.77

0.85

1.2

1.1

—

10.9

—

(3036048) Francisella tularensis Ab [Titer] in Serum

112

1.52

0.84

1.2

—

533.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

138

0.58

0.83

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

283

1.31

0.83

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

283

1.31

0.83

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

283

1.31

0.83

1.2

1.1

—

(4133840)

140

0.57

0.82

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

190

0.63

0.82

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

444

1.24

0.81

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

148

1304

1.14

0.81

1.3

1.2

titre

130.0

213.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

237

0.67

0.81

1.0

u/ml

0.6

0.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

544

1.21

0.81

1.2

mmol/l

7.7

7.9

0.24

394

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.70

0.80

1.5

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

172

1.40

0.80

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

397

0.75

0.80

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

340

0.73

0.79

1.0

1.1

u/ml

0.1

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

107

924

1.16

0.78

1.4

1.6

iu/l

3.9

4.5

0.30

264

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

163

0.61

0.78

1.7

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

243

2211

1.10

0.78

1.8

1.7

u/l

37.2

38.1

0.25

201

1878

(3011985) Renin [Units/volume] in Plasma

703

1.18

0.77

1.3

1.4

mu/l

62.4

62.7

0.01

618

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

124

0.56

0.77

1.0

3.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1627

15755

1.04

0.77

1.7

1.6

nmol/l

17.2

19.6

11.36

1421

13390

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

450

0.78

0.76

1.2

1.1

—

44.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

232

2547

0.91

0.75

1.3

u/ml

226.3

287.6

0.64

211

2329

(3045424) Erythrocytes [Presence] in Urine

939

0.85

0.74

1.5

1.4

—

(4268621)

414

1.23

0.74

2.2

2.4

—

(3016038) Potassium [Moles/volume] in Urine

414

1.23

0.74

1.1

mmol/l

36.7

35.6

0.12

348

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.84

0.73

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

245

1.31

0.73

1.7

2.2

e6/l

18607.0

4303.0

0.36

178

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

0.72

1.6

2.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.80

0.72

1.0

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.55

0.71

1.2

1.1

g/l

14.5

17.2

0.73

(4211845)

308

1.27

0.71

2.8

3.8

—

(3044007) Cell count panel - Peritoneal fluid

194

1.34

0.71

1.6

2.0

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

170

0.65

0.70

12.2

11.9

mmol/l

0.6

0.01

159

(3007164) IgA [Mass/volume] in Serum or Plasma

804

8409

0.95

0.69

1.4

1.5

g/l

2.9

2.8

0.97

473

4952

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

813

0.85

0.68

1.4

1.5

67.0

63.8

0.29

526

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

319

0.75

0.68

1.0

1.1

nmol/l

5.8

7.7

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.53

0.68

1.1

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.59

0.68

4.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

121

1069

1.13

0.68

1.3

1.2

u/ml

4.0

7.2

0.40

101

(3026692) Albumin [Mass/volume] in Peritoneal fluid

187

1.34

0.68

1.2

1.6

g/l

16.7

13.6

0.92

145

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

117

0.60

0.67

1.0

1.2

—

(3034426) Prothrombin time (PT)

153

1.37

0.66

1.1

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

272

0.73

0.66

1.3

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.53

0.66

2.2

2.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

317

0.76

0.66

1.9

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.61

0.65

1.4

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

178

0.67

0.64

7.9

13.3

nmol/l

1091.0

814.2

1.08

168

(3023323) Follitropin [Units/volume] in Serum or Plasma

548

0.82

0.64

1.3

1.4

iu/l

25.6

25.9

0.02

457

(3016018) Differential panel - Cerebral spinal fluid

493

0.81

0.64

1.2

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

554

5255

1.06

0.64

1.7

1.8

1.7

1.6

1.97

459

4388

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

382

0.78

0.63

1.4

—

(3006462) Nitrate [Presence] in Urine

278

1.26

0.63

3.0

4.0

—

(3004616) Nuclear Ab [Presence] in Serum

611

0.83

0.62

1.4

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2130

21784

0.97

0.61

2.3

2.1

nmol/l

74.7

78.1

6.36

1844

18928

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

352

1.22

0.61

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

352

1.22

0.61

1.3

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

467

0.81

0.60

1.2

1.3

titre

53.3

211.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

138

0.65

0.60

1.3

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.0

—

(3014891) Appearance of Pleural fluid

139

1.37

0.60

2.0

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

141

0.64

0.60

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

122

1.39

0.60

1.1

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

465

0.82

0.58

1.4

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

746

0.86

0.58

2.4

3.5

61.2

59.0

0.37

462

(3008898) HLA-B27 [Presence]

991

0.88

0.58

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.58

0.0

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.51

0.58

1.0

—

(3045716) Anion gap in Serum or Plasma

327

1.22

0.58

2.0

2.3

mmol/l

8.8

9.1

0.30

261

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

332

0.78

0.58

2.3

2.6

33.6

35.9

0.24

124

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

150

0.67

0.58

1.3

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

208

0.72

0.58

1.0

1.1

u/l

1.5

1.2

—

106

(3027944) Amphetamines [Presence] in Urine

557

1.17

0.58

1.4

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

4402

43505

1.03

0.58

29.6

21.3

14.2

13.9

24.46

4286

42408

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

365

0.79

0.57

1.3

2.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

149

1.34

0.57

3.2

2.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5394

54399

0.97

0.57

6.7

5.3

mmol/l

2.0

2.5

307.65

5027

49053

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

287

2679

1.07

0.56

2.3

2.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1985

20296

0.97

0.56

3.4

mmol/l

2.3

0.57

1696

17322

(3025130) Human papilloma virus identified in Specimen

141

1.35

0.56

1.9

1.7

—

(1761868) Lipid panel - Serum or Plasma

1571

16116

0.97

0.55

4.1

3.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

109

974

1.12

0.54

1.2

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

121

1088

1.11

0.54

1.3

1.2

u/ml

7.8

4.8

0.60

162

(3043410) Blood group antigens tested for on Red Blood Cells

195

1.28

0.54

1.4

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

2852

28046

1.03

0.53

4.3

3.9

estimate

0.0

1.98

492

5089

(3037467) Urinalysis macro (dipstick) panel - Urine

4039

39898

1.03

0.53

4.9

4.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

656

1.14

0.52

1.2

1.3

pmol/l

186.4

262.5

2.79

489

(3005719) IgG [Mass/volume] in Serum or Plasma

423

4013

1.06

0.52

2.3

2.6

g/l

10.7

10.8

0.21

391

3626

(3031040) Bacteria [#/volume] in Urine by Automated count

3940

38919

1.03

0.52

5.2

4.9

e6/l

828.4

1734.2

1.16

689

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

501

0.84

0.52

1.3

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

134

0.67

0.51

1.1

2.3

ug/l

2.7

1.1

—

123

(3000764) Benzodiazepines [Presence] in Urine

564

1.15

0.51

1.4

1.9

—

(3011288) Drugs identified in Urine by Screen method

360

1.20

0.51

5.6

2.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

347

0.81

0.50

1.2

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

347

0.81

0.50

1.2

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

2817

27718

1.03

0.50

4.3

3.8

estimate

0.0

0.50

522

5239

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

126

1144

1.10

0.49

1.3

1.2

u/ml

47.9

36.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.43

0.49

1.1

1.3

85.2

76.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.43

0.49

1.1

1.3

95.0

76.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

145

1326

1.10

0.49

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.56

0.48

1.0

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.56

0.48

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

107

0.65

0.48

1.3

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

372

1.18

0.48

2.3

2.1

umol/l

30.8

40.2

—

(40768797) Stomach Pathology biopsy report

747

7741

0.96

0.47

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.49

0.47

2.0

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1491

14558

1.03

0.47

4.3

3.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

387

0.83

0.47

1.0

1.1

u/ml

0.6

1.2

0.48

155

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

154

0.71

0.47

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

101

910

1.11

0.46

1.3

1.2

u/ml

4.2

5.4

0.16

(3021601) Nitrite [Presence] in Urine by Test strip

2808

27660

1.02

0.46

5.9

5.2

estimate

0.0

0.00

537

5307

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

129

1.32

0.45

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

119

0.67

0.45

1.3

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.43

0.45

2.1

1.6

umol/l

65.6

44.0

0.61

(3003888) Timothy IgE Ab [Units/volume] in Serum

396

0.83

0.45

1.0

1.1

u/ml

2.1

4.2

1.18

174

(3009214) Lutropin [Units/volume] in Serum or Plasma

1033

0.90

0.45

1.2

1.4

u/l

9.8

8.0

0.71

834

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.40

0.45

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

348

1.18

0.44

2.4

2.1

—

(3016879) Cocaine [Presence] in Urine

535

1.14

0.44

1.4

1.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

480

0.85

0.43

1.2

1.4

—

(36660697) Celiac disease serology panel - Serum

308

3250

0.95

0.43

1.2

—

(3023410) Appearance of Cerebral spinal fluid

447

0.85

0.43

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

639

0.88

0.43

1.2

miu/ml

117.7

196.6

—

191

(3028300) Cannabinoids [Presence] in Urine

574

1.13

0.42

1.4

1.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

332

1.18

0.41

1.7

1.3

nmol/l

1.4

1.1

0.46

249

(3049717) Cytology report of Urine Cyto stain

330

3469

0.95

0.41

2.6

2.9

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

15.4

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

4.3

—

4.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.47

0.40

2.6

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.40

0.0

1.2

—

3.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

150

1.27

0.40

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

150

1.27

0.40

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

150

1.27

0.40

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

150

1.27

0.40

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

159

1.26

0.40

1.1

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

454

0.86

0.39

1.3

1.9

—

(3019174) dRVVT (LA screen)

1.43

0.39

1.4

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.39

0.0

1.1

—

(40765096) Chromosome analysis panel by Banding

215

0.79

0.39

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

138

1278

1.08

0.38

1.6

1.7

—

(3003181) Sodium [Moles/volume] in Urine

111

1207

0.92

0.38

1.3

mmol/l

63.7

62.4

0.15

960

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.35

0.37

1.3

1.2

mg/l

7.1

7.9

0.18

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

420

1.14

0.37

3.8

3.6

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

169

0.77

0.36

1.2

2.7

—

(3027008) Opiates [Presence] in Urine

572

1.12

0.36

1.4

1.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

134

1.27

0.36

1.3

1.2

g/l

0.3

0.30

102

(40760892) CBC W Ordered Manual Differential panel - Blood

1112

11380

0.97

0.36

4.9

4.6

—

(3014271) Vancomycin [Susceptibility]

487

1.13

0.36

3.3

3.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

481

0.87

0.36

1.5

pmol/l

155.4

259.7

1.23

467

(3036670) Protein [Mass/volume] in Synovial fluid

234

0.81

0.35

1.1

1.2

g/l

42.8

39.6

—

126

(44806420)

245

1.18

0.35

2.1

2.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.36

0.34

1.2

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

116

1251

0.93

0.34

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

489

0.88

0.34

1.2

1.4

—

(3028433) Virus identified in Specimen by Culture

209

1.20

0.33

1.1

—

(40757373) Influenza virus identified in Isolate

154

1.23

0.33

1.3

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

232

0.82

0.33

1.5

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.70

0.33

1.3

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

690

7095

0.97

0.32

3.4

4.1

ug/l

13.6

22.0

0.90

580

5959

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

511

1.12

0.32

1.5

1.6

—

(3045414) Leukocytes [Presence] in Urine

263

2508

1.05

0.32

2.0

1.9

—

(3051101) Glucose [Moles/volume] in Cord blood

146

1.23

0.32

4.3

6.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1059

0.92

0.31

1.2

1.1

u/ml

7.3

10.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.35

0.31

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.35

0.31

28.1

12.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

240

0.83

0.30

1.1

—

(4281824)

409

1.13

0.30

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

798

0.91

0.30

3.2

4.2

umol/l

346.6

340.3

0.15

660

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.30

0.30

1.0

1.1

—

(3003338) MCHC [Mass/volume]

4410

43786

1.02

0.30

31.6

23.0

g/l

331.0

332.3

16.38

4342

43255

(3042010) Triglyceride [Moles/volume] in Pleural fluid

129

1.24

0.30

1.4

1.2

mmol/l

0.4

1.6

—

(40768441) Liver Pathology biopsy report

381

1.13

0.30

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.33

0.30

1.9

2.0

—

(3047189) Immunofixation for 24 hour Urine

364

1.13

0.28

1.2

1.6

—

(3003694) ABO and Rh group [Type] in Blood

1387

14098

0.98

0.28

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

117

0.77

0.27

1.1

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

233

1.16

0.27

1.2

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

633

1.09

0.27

1.3

e6/l

52381.3

170427.9

2.58

438

(3000012) Reticulocyte production index

432

1.11

0.27

1.8

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

131

1.22

0.27

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

458

0.89

0.26

1.1

u/ml

0.7

1.9

1.16

184

(3014133) Dog dander IgE Ab [Units/volume] in Serum

289

0.86

0.26

1.0

1.1

u/ml

0.2

2.1

—

115

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

171

1625

1.05

0.26

1.4

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

225

0.84

0.26

1.1

ng/l

643.4

500.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

172

1635

1.05

0.26

1.7

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

178

1.18

0.26

1.1

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

214

0.84

0.26

7.5

5.4

77.8

71.4

0.90

173

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.67

0.25

1.0

—

(3015183) Erythrocyte sedimentation rate

149

0.80

0.25

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.25

0.25

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

224

0.85

0.25

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

425

1.11

0.25

9.3

12.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

137

0.80

0.24

1.5

1.8

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

217

1.15

0.24

2.9

2.8

umol/l

25.2

28.9

0.88

158

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.28

0.24

1.3

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

436

1.10

0.24

1.4

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

736

7516

0.98

0.24

1.3

1.2

iu/ml

55.8

39.8

0.98

209

2256

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

765

0.93

0.23

1.9

1.5

—

(21494434) Karyotype in Bone marrow

620

1.08

0.23

1.1

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

143

1.19

0.23

1.6

2.6

225.8

212.2

0.16

133

(3047007) Chlamydophila sp Ab [Presence] in Serum

495

1.09

0.23

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1383

14022

0.98

0.22

1.8

1.7

pmol/l

21972729.5

26283601.2

0.14

1156

11300

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.25

0.22

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.27

0.22

1.3

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

360

3497

1.03

0.21

2.6

2.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.19

0.21

1.0

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.1

—

2472.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

59.8

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

1839.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

987

0.94

0.21

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

165

1723

0.96

0.21

1.4

1.5

ug/g

265.9

256.7

0.24

105

1048

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

119

1253

0.95

0.21

3.2

3.6

u/ml

39.9

76.8

2.63

113

1198

(3000285) Sodium [Moles/volume] in Blood

104

0.77

0.21

1.4

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

377

0.90

0.21

2.4

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

192

1.15

0.20

1.1

1.0

iu/ml

10.1

11.2

—

(40761535) Cells panel - Urine sediment

566

5539

1.02

0.20

3.9

3.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.20

0.0

3.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.25

0.20

3.0

4.6

—

(4146454)

779

0.94

0.20

3.0

2.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2164

21439

1.01

0.19

4.7

4.2

—

(3048879) Bone marrow aspiration report

239

0.88

0.19

1.1

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

260

0.88

0.19

1.0

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

385

0.91

0.19

1.5

2.0

13.3

16.3

0.55

145

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

122

0.82

0.19

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

416

0.91

0.19

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

622

0.93

0.18

3.2

mg/l

195.9

60.2

0.74

473

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.21

0.18

1.0

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.21

0.18

1.0

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.21

0.18

1.0

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

794

1.06

0.18

1.0

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

338

1.10

0.18

1.6

2.3

e6/l

395.9

512.1

0.67

283

(3008757) Leukocyte morphology finding [Identifier] in Blood

785

1.06

0.17

3.2

4.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.15

0.17

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.13

0.17

1.1

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

184

0.87

0.17

1.4

1.9

ug/l

51.6

53.4

0.08

176

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.11

0.17

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

129

1.16

0.17

1.3

1.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

728

1.06

0.17

3.4

3.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

257

0.89

0.17

1.0

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

529

5390

0.98

0.16

5.0

4.0

mmol/l

1.2

1.55

480

4677

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.16

0.16

6.6

3.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

369

1.08

0.16

1.8

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

196

1.12

0.16

1.0

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

105

1004

1.05

0.16

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

266

0.90

0.15

1.0

1.1

u/ml

0.4

2.5

2.15

102

(3005988) Vibrio sp identified in Specimen by Organism specific culture

770

0.95

0.15

1.3

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.75

0.15

5.7

4.9

ug/min

61.2

48.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

276

0.91

0.15

1.5

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

178

1.12

0.15

2.7

1.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.11

0.15

1.3

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

134

1291

1.04

0.15

1.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5273

52885

0.99

0.15

6.0

4.7

mmol/l

3.7

4.4

307.65

4934

47936

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.10

0.15

1.0

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.08

0.14

1.0

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

768

0.95

0.14

1.3

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

498

4895

1.02

0.14

4.0

0.1

2.21

158

1508

(3017181) Myelocytes/100 leukocytes in Blood

526

5173

1.02

0.14

4.0

3.9

0.9

1.0

0.32

171

1621

(3026389) Candida sp identified in Specimen by Organism specific culture

645

1.05

0.14

1.3

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

239

2451

0.97

0.14

3.2

3.4

u/ml

523.4

2497.2

1.01

202

2114

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

160

1.13

0.14

1.4

2.5

mmol/l

7.2

8.2

0.77

100

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.19

0.14

1.1

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.83

0.13

1.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

387

0.93

0.13

1.4

1.1

—

3.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.17

0.13

1.4

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

785

0.95

0.13

1.3

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

161

1.12

0.13

1.7

1.4

iu/ml

1820656.0

732880.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

153

1484

1.03

0.12

1.6

iu/ml

5.8

14.1

0.62

362

(3024522) Salmonella sp identified in Specimen by Organism specific culture

774

0.96

0.12

1.3

1.4

—

(3037121) Protein [Mass/volume] in Urine

233

2276

1.02

0.12

2.7

3.1

g/l

0.4

0.3

1.49

136

1002

(3045142) Bone marrow Pathology biopsy report

763

0.96

0.12

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

208

2131

0.98

0.12

1.1

iu/ml

104.4

122.7

0.18

706

(1002224) Polysomnography panel

162

1575

1.03

0.12

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

426

0.94

0.12

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

171

1664

1.03

0.12

1.4

1.5

—

(40761536) Microorganisms panel - Urine sediment

499

4917

1.02

0.12

4.6

4.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

152

1477

1.03

0.11

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

162

1.11

0.11

1.3

2.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

466

0.94

0.11

1.2

1.1

u/ml

3.8

3.0

0.31

157

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

612

1.05

0.11

1.5

24.2

24.9

0.05

395

(21494815) CD4 cells/100 lymphocytes in Specimen

434

0.94

0.10

1.5

2.1

47.0

40.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

472

4656

1.01

0.10

3.9

3.8

0.6

0.7

0.27

118

1164

(3011412) CD3 cells [#/volume] in Blood

505

1.05

0.10

1.6

2.2

e9/l

1.0

1.1

0.25

310

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

769

0.96

0.10

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

769

0.96

0.10

1.3

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.11

0.09

1.4

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

463

0.95

0.09

2.0

1.9

ug/l

5.9

3.3

1.32

399

(44806071)

1.09

0.09

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

585

1.04

0.09

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.06

0.09

1.4

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

289

0.93

0.09

1.3

ug/l

238.5

385.1

0.33

156

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.15

0.09

2.0

3.0

u/field

0.4

—

(3025159) Blasts/100 leukocytes in Blood

449

4546

0.99

0.09

4.3

4.0

0.0

0.2

1.15

132

1262

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.05

0.08

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

1.05

0.08

1.2

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

107

1.12

0.08

1.7

4.8

u/l

36.5

40.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

692

6982

0.99

0.08

1.3

1.2

u/ml

17.6

14.8

0.33

248

2438

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

267

0.94

0.08

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.81

0.08

1.4

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.79

0.08

9.6

9.5

umol/l

0.4

0.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

150

1468

1.02

0.08

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

151

1478

1.02

0.08

1.3

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

117

1199

0.98

0.08

3.3

3.6

1.6

1.5

0.10

901

(3020650) Glucose [Presence] in Urine

123

0.89

0.08

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5515

55234

0.99

0.08

24.4

17.7

mg/l

28.8

28.5

0.21

4880

45619

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.03

0.07

1.1

2.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.84

0.07

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.83

0.07

1.7

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

530

0.96

0.07

1.5

1.6

u/ml

18.9

29.8

—

118

(3021788) Differential panel - Synovial fluid

119

1163

1.02

0.07

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

196

1.07

0.07

1.7

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

363

1.05

0.07

1.4

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

377

0.95

0.07

1.8

2.2

e6/l

459.6

554.1

0.37

154

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1173

11794

0.99

0.07

3.2

mmol/l

2.5

1.48

983

10214

(3002523) Influenza virus A Ag [Presence] in Specimen

427

0.96

0.06

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

101

0.89

0.06

1.0

1.3

—

(44813793)

246

1.06

0.06

1.1

1.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

151

1484

1.02

0.06

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

197

1.07

0.06

1.0

1.2

g/l

—

0.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

152

0.92

0.06

1.1

miu/ml

1495.1

1598.9

0.15

152

(3025941) Bacteria identified in Stool by Culture

279

2757

1.01

0.06

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

572

1.03

0.06

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

572

1.03

0.06

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

572

1.03

0.06

1.5

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

345

0.96

0.06

3.1

3.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

121

0.91

0.06

1.5

1.2

u/l

54.2

326.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

132

1297

1.02

0.05

1.3

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

178

1.07

0.05

1.0

1.1

—

(3036603) Volume of Urine

394

0.96

0.05

1.3

1.7

1982.0

1828.9

0.36

115

(3038177) Helicobacter pylori Ab [Presence] in Serum

634

1.03

0.05

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

185

1872

0.99

0.04

1.2

1.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

101

1.09

0.04

1.7

1.4

73.5

75.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

271

0.96

0.04

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

507

1.03

0.04

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

139

0.94

0.03

1.2

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

139

0.94

0.03

1.8

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5233

52369

1.00

0.03

5.9

4.7

mmol/l

1.2

1.4

201.67

4861

47108

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

240

0.96

0.03

2.3

2.1

umol/l

64.1

55.7

0.46

190

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

149

0.94

0.03

1.1

1.2

—

(3042631) Mycobacterium sp identified in Specimen

113

1116

1.01

0.03

2.7

2.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

239

0.96

0.02

1.2

mmol/l

5.7

6.2

1.42

225

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

239

0.96

0.02

1.6

1.4

19.3

22.0

0.16

191

(3029937) Albumin [Presence] in Urine by Test strip

1556

15529

1.00

0.02

4.6

4.2

estimate

0.0

0.33

488

4897

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

271

1.03

0.02

1.4

2.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

299

0.97

0.02

1.2

1.3

u/ml

0.3

1.9

2.08

156

(3048689) Calprotectin [Mass/mass] in Stool

495

4931

1.00

0.02

2.4

2.2

ug/g

198.6

167.8

0.65

401

3863

(3025018) Bordetella pertussis Ab [Titer] in Serum

178

0.95

0.02

1.4

1.2

—

(4015189)

198

0.96

0.02

2.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.08

0.02

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

113

1.06

0.01

1.8

1.6

ng/l

226.9

149.2

0.81

113

(3032773) Endomysium IgG Ab [Titer] in Serum

337

0.98

0.01

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

347

0.98

0.01

1.4

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

347

0.98

0.01

1.4

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

347

0.98

0.01

1.4

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

347

0.98

0.01

1.4

1.9

—

(3025577) Chromium [Mass/volume] in Blood

447

0.98

0.01

2.0

ug/l

2.4

2.0

0.82

363

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

877

0.99

0.01

2.1

mg/l

24.0

24.9

0.06

210

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

104

1.06

0.01

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

226

0.97

0.00

1.3

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

256

0.98

0.00

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

264

1.02

0.00

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

119

1.01

0.00

2.2

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

175

1.03

0.00

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

111

0.99

0.00

1.1

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

173

0.98

0.00

1.4

1.2

mmol/l

1.5

—

104

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

266

1.01

0.00

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.03

0.00

1.0

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

136

1.03

0.00

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

992

1.00

0.00

1.9

2.1

31.9

32.8

1.29

984

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

563

0.99

0.00

1.3

1.2

nmol/l

1.2

1.5

1.82

498

(4027681)

212

0.99

0.00

1.3

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

268

1.01

0.00

1.4

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

268

1.01

0.00

1.4

2.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

115

0.96

0.00

1.1

1.4

—

101.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

191

0.99

0.00

1.2

1.3

umol/l

10.4

24.7

8.23

185

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

144

0.97

0.00

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

113

0.97

0.00

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.0

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.8

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

35.9

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.85

0.00

1.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.92

0.00

1.3

1.1

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.98

0.00

2.1

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

0.0

6.2

—

7.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.95

0.00

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.01

0.00

1.8

2.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.4

—

0.3

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: I9_STEMI – Myocardial infarction, with ST-elevation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Myocardial infarction, with ST-elevation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Myocardial infarction, with ST-elevation (I9_STEMI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints